SAB Biotherapeutics, Inc. Annual Interest Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
SAB Biotherapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2023.
  • SAB Biotherapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $93.1K, a 23.6% increase year-over-year.
  • SAB Biotherapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $317K, a 2.75% decline year-over-year.
  • SAB Biotherapeutics, Inc. annual Interest Expense for 2023 was $315K, a 4.54% increase from 2022.
  • SAB Biotherapeutics, Inc. annual Interest Expense for 2022 was $302K, a 2.42% increase from 2021.
  • SAB Biotherapeutics, Inc. annual Interest Expense for 2021 was $294K, a 37.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $315K +$13.7K +4.54% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $302K +$7.13K +2.42% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $294K -$175K -37.2% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 $469K Jan 1, 2020 Dec 31, 2020 10-K/A 2023-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.